M.H. Grant

1.7k total citations
53 papers, 1.2k citations indexed

About

M.H. Grant is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, M.H. Grant has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 13 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in M.H. Grant's work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (11 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). M.H. Grant is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (11 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). M.H. Grant collaborates with scholars based in United Kingdom, Australia and Canada. M.H. Grant's co-authors include Susan J. Duthie, M.D. Burke, William T. Melvin, Hamed Doostdar, Gabrielle Hawksworth, C. MacDonald, G. McKay, R. Macnair, J C Petrie and Mekala Gunaratnam and has published in prestigious journals such as Biomaterials, FEBS Letters and Journal of Hepatology.

In The Last Decade

M.H. Grant

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.H. Grant United Kingdom 21 351 336 206 183 179 53 1.2k
Jin Seok Kang South Korea 16 154 0.4× 401 1.2× 87 0.4× 99 0.5× 108 0.6× 78 1.5k
Katsuhiro Isoda Japan 18 150 0.4× 404 1.2× 189 0.9× 53 0.3× 133 0.7× 45 1.4k
Eun‐Kyung Ahn South Korea 21 147 0.4× 449 1.3× 139 0.7× 52 0.3× 78 0.4× 67 1.1k
Hildegard Herman Romania 22 90 0.3× 335 1.0× 85 0.4× 101 0.6× 88 0.5× 61 1.3k
Matthew Stoner United States 22 170 0.5× 668 2.0× 60 0.3× 289 1.6× 21 0.1× 27 1.7k
Yongping Huang China 13 89 0.3× 365 1.1× 61 0.3× 80 0.4× 38 0.2× 29 1.2k
Lijie Jiang China 23 49 0.1× 942 2.8× 210 1.0× 163 0.9× 108 0.6× 100 2.1k
Kenichi Sudo Japan 19 280 0.8× 350 1.0× 249 1.2× 358 2.0× 23 0.1× 100 1.5k
Seokjoo Yoon South Korea 20 119 0.3× 410 1.2× 42 0.2× 68 0.4× 60 0.3× 80 1.2k
Yifan Yang China 23 100 0.3× 461 1.4× 172 0.8× 85 0.5× 18 0.1× 63 1.4k

Countries citing papers authored by M.H. Grant

Since Specialization
Citations

This map shows the geographic impact of M.H. Grant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.H. Grant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.H. Grant more than expected).

Fields of papers citing papers by M.H. Grant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.H. Grant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.H. Grant. The network helps show where M.H. Grant may publish in the future.

Co-authorship network of co-authors of M.H. Grant

This figure shows the co-authorship network connecting the top 25 collaborators of M.H. Grant. A scholar is included among the top collaborators of M.H. Grant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.H. Grant. M.H. Grant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scott, Fraser J., Abedawn I. Khalaf, Catherine Henderson, et al.. (2016). An evaluation of Minor Groove Binders as anti-lung cancer therapeutics. Bioorganic & Medicinal Chemistry Letters. 26(15). 3478–3486. 13 indexed citations
2.
Ellis, Lucy C.J., M.H. Grant, Gabrielle Hawksworth, & Richard Weaver. (2014). Quantification of biliary excretion and sinusoidal excretion of 5(6)-carboxy-2′,7′-dichlorofluorescein (CDF) in cultured hepatocytes isolated from Sprague Dawley, Wistar and Mrp2-deficient Wistar (TR−) rats. Toxicology in Vitro. 28(6). 1165–1175. 10 indexed citations
3.
Sandven, Stein, et al.. (2012). EUMIS - an open portal framework for interoperable marine environmental services. EGUGA. 10503.
4.
Raghunathan, Vijay Krishna, Elizabeth Ellis, & M.H. Grant. (2009). Response to chronic exposure to hexavalent chromium in human monocytes. Toxicology in Vitro. 23(4). 647–652. 16 indexed citations
5.
Raghunathan, Vijay Krishna, J.N.A. Tettey, Elizabeth Ellis, & M.H. Grant. (2008). Comparative chronic in vitro toxicity of hexavalent chromium to osteoblasts and monocytes. Journal of Biomedical Materials Research Part A. 88A(2). 543–550. 18 indexed citations
6.
McLellan, Lesley I., et al.. (2006). Reduced glutathione levels and expression of the enzymes of glutathione synthesis in cryopreserved hepatocyte monolayer cultures. Toxicology in Vitro. 21(3). 527–532. 13 indexed citations
7.
Carter, Katharine C., Alexander B. Mullen, Geoffrey D. Coxon, et al.. (2006). Identification of the benzodiazepines as a new class of antileishmanial agent. Bioorganic & Medicinal Chemistry Letters. 17(3). 624–627. 40 indexed citations
8.
Merry, Jill, et al.. (2006). The mechanical properties of calcium phospate ceramics modified by collagen coating and populated by osteoblasts. Journal of Materials Science Materials in Medicine. 17(1). 43–48. 11 indexed citations
9.
Savage, Robert L., et al.. (2002). Growth and viability of osteoblasts on hydroxyapatite and tri-calcium phosphate ceramics: the effect of collagen coating. Strathprints: The University of Strathclyde institutional repository (University of Strathclyde). 4(2). 57–57. 2 indexed citations
10.
Stevenson, David, et al.. (2002). Viability and function of cryopreserved rat hepatocyte monolayers as a function of cryopreservation media composition. Toxicology. 178. 55–56.
11.
Reid, Fiona, et al.. (2000). Comparison of RAP-PCR analysis of gene expression in fresh and immortalised rat hepatocyte cell lines. Cytotechnology. 34(1-2). 159–163. 1 indexed citations
13.
Grant, M.H., et al.. (1994). Studies on nickel-induced inhibition of fibroblast growth. Toxicology in Vitro. 8(2). 191–195. 6 indexed citations
15.
Doostdar, Hamed, M.H. Grant, William T. Melvin, C. Roland Wolf, & M.D. Burke. (1993). The effects of inducing agents on cytochrome P450 and UDP-glucuronyltransferase activities in human HEPG2 hepatoma cells. Biochemical Pharmacology. 46(4). 629–635. 66 indexed citations
16.
Grant, M.H., et al.. (1993). Cryopreservation of human adult hepatocytes for use in drug metabolism and toxicity studies. Xenobiotica. 23(12). 1399–1409. 50 indexed citations
18.
Doostdar, Hamed, Abraham Demoz, M.D. Burke, William T. Melvin, & M.H. Grant. (1990). Variation in drug-metabolizing enzyme activities during the growth of human Hep G2 hepatoma cells. Xenobiotica. 20(4). 435–441. 44 indexed citations
19.
Grant, M.H. & Susan J. Duthie. (1988). The cytotoxicity of menadione in hepatocytes isolated from streptozotocin-induced diabetic rats. Biochemical Pharmacology. 37(19). 3793–3796. 6 indexed citations
20.
Duthie, Susan J., Catherine S. Coleman, & M.H. Grant. (1988). Status of reduced glutathione in the human hepatoma cell line, HEP G2. Biochemical Pharmacology. 37(17). 3365–3368. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026